Zobrazeno 1 - 4
of 4
pro vyhledávání: '"John C. Hollerton"'
Autor:
Richard J. Upton, Max W. Robinson, John C. Hollerton, Bob Boughtflower, Sean M. Lynn, Steve C. Besley, Simon A. Readshaw, Alan P. Hill
Publikováno v:
Analytical Chemistry. 89:1772-1777
Universal quantitative detection without the need for analyte reference standards would offer substantial benefits in many areas of analytical science. The quantitative capability of high-performance liquid chromatography (HPLC) with charged aerosol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e4b3c63c67b2f4285f143f552e13d2f
https://doi.org/10.1021/acs.analchem.6b04060
https://doi.org/10.1021/acs.analchem.6b04060
Autor:
Philip J. Sidebottom, Sean M. Lynn, Stefano Provera, Richard J. Upton, John C. Hollerton, Roger D. Farrant
Publikováno v:
Magnetic Resonance in Chemistry. 48:753-762
We have developed QUANTAS (QUANTification by Artificial Signal), which is a software-based protocol for concentration measurement by NMR. QUANTAS is an absolute intensity external standard method for quantification by NMR that compensates for various
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::490960533cf3cf0ff1be340391bc157c
https://doi.org/10.1002/mrc.2647
https://doi.org/10.1002/mrc.2647
Autor:
John C. Hollerton
Publikováno v:
eMagRes
Achieving high-throughput NMR requires optimization of all of the individual steps in the process from sample preparation through to data interpretation. This article outlines some of the considerations needed to ensure that the complete process is o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7c35faec03a76c80679f5cb72e302d4
https://doi.org/10.1002/9780470034590.emrstm1390
https://doi.org/10.1002/9780470034590.emrstm1390
Autor:
Drake S. Eggleston, Nicholas L. Taylor, John C. Hollerton, Keith A. Brinded, Simon A. Readshaw, Stephen J. Lane
Publikováno v:
Drug Discovery Today. 11:267-272
Understanding the quality of a screening collection is the first step to improving it and, as a result, the quality of the screening process. This article outlines how this issue was approached at GlaxoSmithKline and some of the hurdles that needed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a91b2ca61674e8b7887684aaead26adb
https://doi.org/10.1016/s1359-6446(05)03730-x
https://doi.org/10.1016/s1359-6446(05)03730-x